BiotechTube
Home/Opthea/Mike Gerometta
MG

Mike Gerometta

Chief Technology Officer

Opthea

Therapeutic Areas

Rare Disease (Pulmonary)Ophthalmology

Opthea Pipeline

DrugIndicationPhase
Sozinibercept (OPT-302)Lymphangioleiomyomatosis (LAM)Phase 2 (Planned)

Leadership Team at Opthea

JM
Jeremy M. Levin
Chairman of the Board
KC
Kathy Connell
Non-Executive Director and Chair of Remuneration Committee
SM
Stuart Mudge
Chief Operating Officer
HG
Hamish George
Chief Finance Officer
View full Opthea profile